Wellnex Life (ASX/AIM: WNX) is pleased to announce its Half-Year Financial Report, ending 31 December 2025. View the full announcement ๐ https://t.co/AKevZBJ9Yc
๐ฒ Stay up-to-date on company news and announcements: https://t.co/eYK2ysnVTl
#WellnessIndustry#MarketUpdate
Wellnex Life (ASX/AIM: WNX) is pleased to release an update for the quarter ending 31 December 2025. Ash Vesali will be hosting an Investor Briefing on 2nd February at 11am (AEDT). Register ๐ https://t.co/XQI0SWUUnv
View announcement ๐ https://t.co/S0e8nny1UY
Wellnex Life $WNX is pleased to provide a trading update for the period January to April 2025.
View ๐ https://t.co/mPHPkh6sOM
Wellnex continues to see growth across the whole business which the Board expects to continue for the remainder of FY25 and into FY26.
#Health#Wellness
.@WellnexLife Limited, an innovative brand and distribution company based in Melbourne and focused on consumer health and wellness products, has celebrated its admission to AIM.
Find out more: https://t.co/yKczzID7FS
#AIM30#AIM#Health#Wellness
Wellnex Life $WNX announces that it has received initial conditional binding commitments through its Lead Brokers of A$9 million.
View the announcement ๐ https://t.co/NmPUc32BUS
#Health#Wellness#LSE
$WNX MD Zack Bozinovski with @StockheadAU Health & Biotech journalist Nadine McGrath, on the โVital Signs" podcast๐ https://t.co/xKBRlAaNVu
He discusses the companyโs brand portfolio & game-changing partnerships, ahead of its plans to dual list on the London Stock Exchange.
Special Report ๐ฃ Wellnex Life $WNX has achieved a key milestone with a new market authorisation by Australiaโs Therapeutic Goods Administration for a liquid paracetamol plus caffeine soft gel.
Read more @australian๐ https://t.co/obBhhGZVtk
#Health#Wellness
Wellnex Life $WNX is in the process of raising up to $16 million ahead of a secondary London listing, having transformed from a low-margin brand broker to an own-brand powerhouse.
Read more, @australian ๐ https://t.co/YwqFnXyyv6
#LSE#Wellness#Health#Haleon
๐ฃ Wellnex Life $WNX is pleased to report record sales of $3 million per month for November and December 2024 with its dual listing on the LSE imminent. Read more ๐ https://t.co/Mn5729VnlB
๐To stay up-to-date on company news: https://t.co/mqZn6QtPhD
#Wellness#Health
Wellnex Life $WNX announces the approval of a new Market Authorisation (MA) for a liquid paracetamol plus caffeine soft gel, after the successful submission with TGA of the pharmaceutical dossier.
View ๐ https://t.co/cfSUCaCy3z
#Wellness#Health
$WNX MD Zack Bozinovski shares insights on why 2024 was a transformational year for the company, as we target a dual listing on the London Stock Exchange #LSE in early 2025๐ https://t.co/71kIMzE8mn
๐Stay up-to-date on company news: https://t.co/mhuTx9jfpx
#Health#Wellness
Wellnex Life Limited $WNX is pleased to provide a company update for the July to December 2024 period, which included another strong month in December with sales of $3.02 million.
View ๐ https://t.co/lWr9fXCdxe
#Health#Wellness
Special Report: ๐ฃ $WNX targets a dual listing on the London Stock Exchange (#LSE) early in the new year, with the company reporting its strongest November on record with sales of $3.16 million. Read more ๐ https://t.co/lchYNHsTWa
#Wellness#Health
Wellnex Life $WNX is pleased to provide a company update for the July to November period, which included a record month in November with sales of $3.16 million. View ๐ https://t.co/zyNAenOa2t
#Health#Wellness
Wellnex Life $WNX is pleased to provide an update on the proposed dual listing on the main market of the London Stock Exchange (#LSE).
View ๐ https://t.co/3SjQeK1fXa
#Health#Wellness
$WNX is pleased to announce the appointment of Mr George Tambassis as Non-executive Chair of Wellnex Life. View ๐ https://t.co/J95FfMoo7Y
Mr Tambassis has a long history of success in the consumer health and pharmaceutical market over a 35 year period.
#Health#Wellness
$WNX announces the launch of Wellness Life, a new medicinal cannabis brand will officially launch on 1 July 2024. View ๐ https://t.co/voi6b8SIxL
This marks a significant step in providing high-quality #MedicinalCannabis products to the burgeoning SAS-B market in Australia.
$WNX has successfully reintroduced the Pain Away brand through a strategic partnership with Chemist Warehouse New Zealand.
View ๐ https://t.co/lreoFGyKbS
This reintroduction marks a significant step in Wellnex Life's export growth strategy for the #PainAway brand.
#Health
Wellnex Life $WNX has commenced the process to dual list on the London Stock Exchange that will provide a pathway to accelerate our growth both domestically and internationally. View ๐ https://t.co/fztIEbzbO7
#Health#Wellness#LSE